Jernigan MG et al. – Among colistin– and pan–drug–resistant isolates, synergy was identified in 60 and 67%, respectively. All other combinations were inferior. Authors are currently evaluating the combination of doripenem and colistin as a frontline therapy for KPC infection. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close